Lipinski Marta M, Yuan Junying
Harvard Medical School, Department of Cell Biology, 240 Longwood Ave, Boston MA 02115, USA.
Curr Opin Pharmacol. 2004 Feb;4(1):85-90. doi: 10.1016/j.coph.2003.09.008.
Abnormal protein aggregation is a hallmark of many neurodegenerative diseases. However, the mechanism by which protein aggregates induce neurodegneration remains controversial. Recently proposed mechanisms of neuronal death in polyglutamine expansion diseases include activation of caspases and associated cell death pathways, interference with transcriptional regulation, downregulation of survival pathways and obstruction of axonal transport. Because the expression of expanded polyglutamine in selected neuronal populations can adversely affect multiple aspects of neuronal survival and function, we propose that effective therapeutic approaches might have to target the upstream mechanism of neurotoxicity by selectively inhibiting the formation of intraneuronal aggregates and increasing the degradation of mutant proteins.
异常蛋白质聚集是许多神经退行性疾病的一个标志。然而,蛋白质聚集体诱导神经退行性变的机制仍存在争议。最近提出的多聚谷氨酰胺扩展疾病中神经元死亡的机制包括半胱天冬酶的激活及相关细胞死亡途径、对转录调控的干扰、生存途径的下调和轴突运输的阻碍。由于在特定神经元群体中扩展的多聚谷氨酰胺的表达可能对神经元存活和功能的多个方面产生不利影响,我们提出有效的治疗方法可能必须通过选择性抑制神经元内聚集体的形成和增加突变蛋白的降解来靶向神经毒性的上游机制。